Why Diet Drugs Matter for Hospitality

About

Once reserved for diabetes care, GLP-1 medicines like Wegovy and Mounjaro are now in the headlines – and in handbags – across the UK. They’ve been hailed as game-changers for tackling obesity, but they’re also sparking big conversations about cost, access, side effects and how they might reshape industries from food retail to hospitality.

This report looks at how the growing proportion of GLP-1 users are reshaping eating, drinking and socialising habits. It covers everything from food and drink preferences, to how and why GLP-1 users choose specific venues to go out to.

Release date

October 2025

Format

PDF Report. 14 pages